Experimental validation shows remimazolam alleviates lung injury by inhibiting ferroptosis, suggesting therapeutic potential in ALI management.
This study demonstrated that REM alleviated LPS-induced lung injury by inhibiting ferroptosis, potentially through upregulation of HO-1 and restoration of the SLC7A11-GSH-GPX4 axis. These findings provide novel mechanistic insights into the anti-ferroptotic effects of REM and highlight its therapeutic potential in ALI/ARDS management.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: